You are viewing EMENA

Choose Your Location:
    • United States
    • Canada
    • Mexico
  • South America
  • EMENA
  • Sub-Saharan Africa
  • Russia
  • South Asia
  • Asia Pacific
  • China
  • Global

Choose Your Location:

north-america-noactive usa-active canada-active mexico-active
  • United States
  • Canada
  • Mexico
north-america-noactive north-america-active
South America
north-america-noactive north-america-active
EMENA
Africa Africa
Sub-Saharan Africa
Russia Russia
Russia
South Asia South Asia
South Asia
Asia Asia
Asia Pacific
China China
China
global-site-noactive global-site-active
Global

Butyric Acid for Better Gut Health

Meet ButiShield™: A Next-Generation Biotic Solution

Kemin’s ButiShield™ is a clinically studied, low-odor source of butyric acid designed to:1-4

  • Fortify the intestinal barrier function and integrity.
  • Promote and shape a healthy microbiome and gastrointestinal environment.
  • Signal processes at the cellular and DNA level.

Delivered via advanced MicroPEARLS™ technology, ButiShield™ ensures sustained and controlled release for superior efficacy and handling.5,6

Unlock the power of butyrate! Download our free infographic to learn why it’s essential for your gut health and discover how ButiShield™ can elevate your next formulation.

Next-Gen Biotic for Intestinal Health and Beyond - Infographic Thumbnail

The Fiber Gap: A Global Health Challenge

Nearly half of consumers recognize the importance of the gut microbiome7, but most diets lack enough fiber—leading to fewer beneficial metabolites like butyrate and a weakened gut barrier.

Across Europe, fresh fruit and vegetable consumption continues to decline. In 2023, average intake was roughly 340 grams per day—about 60 grams below the World Health Organization’s recommended minimum8.

Why Butyrate Matters

Dietary fiber fuels beneficial gut bacteria, generating short‑chain fatty acids (SCFAs) such as butyrate. Modern diets often lack the fiber needed to produce sufficient butyrate—creating a nutritional gap that ButiShield™ is uniquely positioned to help fill.9,10

Elevate Your Gut Health Portfolio with ButiShield™

Join leading European brands already formulating with ButiShield™ to meet rising consumer demand for digestive health solutions.

Fill out the form to access the ButiShield™ infographic and trial data.

References:

1. Peng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R. & Lin, J. Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP‑Activated Protein Kinase in Caco‑2 Cell Monolayers. J. Nutr. 139, 1619–1625 (2009).2. Knudsen, K. E. B. et al. Impact of diet‑modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10 (2018).3. Facchin, S. et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterol. Motil. 32, 13–25 (2020).4. Yan, H. & Ajuwon, K. M. Butyrate modifies intestinal barrier function in IPEC‑J2 cells through selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS One 12, e0179586 (2017).5. Maci, S. & Deters, E. ButiShield™ Next Generation Encapsulation Technology for Sustained Release of Butyric Acid in the Gut. Kemin Tech. Lit. KHTL‑017‑183 (2023).6. Scientific Frontiers: ButiShield™ supports adults with mild GI symptoms. NutraIngredients. https://www.nutraingredients.com/Scientific-Frontiers/scientific-frontiers-butishield-supports-adults-with-mild-gi-symptoms-kemin-health-and-human-nutrition/7. FMCG Gurus. Trend Report: Gut Microbiome — Understanding, Awareness & Impact on Health. March 2025.8. “Fresh Food Market in Europe.” Statista (2024). www.statista.com/topics/12762/fresh-food-market-in-europe/9. Zeng, H., Umar, S., Rust, B., Lazarova, D., & Bordonaro, M. Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer. Int. J. Mol. Sci. 20, 1214 (2019).10. Donohoe, D. R., et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13, 517–526 (2011).

*These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers. This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should be considered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.